XML 60 R20.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Fair Value Measurements and Short-Term Investments (Tables)
12 Months Ended
Dec. 31, 2019
Fair Value Disclosures [Abstract]  
Schedule of Short-term Investments Available-for-sale
The Company did not have any short-term investments for the year ended December 31, 2018. As of December 31, 2019, all of the Company’s investments had remaining maturities of less than 12 months. The following is a summary of the Company’s short-term investments, considered available-for-sale, as of December 31, 2019:
 
Amortized
 
Gross Unrealized
 
Estimated
 
Cost
 
Gains
 
Losses
 
Fair Value
Available-for-sale securities
 
 
 
 
 
 
 
U.S treasury securities
$
19,905

 
$
6

 
$

 
$
19,911

Schedule Assets and Liabilities Measured on Recurring Basis
The Company measures and reports certain financial instruments as assets and liabilities at fair value on a recurring basis. The fair value of these instruments was as follows:
 
As of December 31, 2019
 
Fair Value
 
Level 1
 
Level 2
 
Level 3
Available-for-sale debt securities
 
 
 
 
 
 
 
U.S treasury securities
$
19,911

 
$
19,911

 
$

 
$

Liabilities
 
 
 
 
 
 
 
Contingent royalty obligation payable to Evolus Founders
$
44,683

 
$

 
$

 
$
44,683

 
As of December 31, 2018
 
Fair Value
 
Level 1
 
Level 2
 
Level 3
Liabilities
 
 
 
 
 
 
 
Contingent royalty obligation payable to Evolus Founders
$
50,200

 
$

 
$

 
$
50,200

Schedule of Reconciliation of Fair Value Measurement for Contingent Royalty Obligation Payable
The following table shows a reconciliation of the beginning and ending fair value measurements of the contingent royalty obligation payable:
 
Year Ended December 31,
 
2019
 
2018
Fair value, beginning of period
$
50,200

 
$

Payments
(9,677
)
 

Assumption of the royalty obligation payable to Evolus Founders

 
39,700

Change in fair value recorded in operating expenses
4,160

 
10,500

Fair value, end of period
$
44,683

 
$
50,200